Key result
Meeting national sodium reduction targets could prevent ~59,000 incident CKD events by 2030.
Why the study?
Excess sodium intake raises blood pressure and increases CKD risk, but the impact of reduced sodium intake on future CKD burden in Australia required estimation.
Does achieving national dietary sodium reduction targets prevent incident chronic kidney disease, avert CKD-related mortality, and reduce healthcare costs in the Australian adult population?
Does achieving national dietary sodium reduction targets prevent incident chronic kidney disease, avert CKD-related mortality, and reduce healthcare costs in the Australian adult population?
Lowering population-level sodium consumption to recommended targets could yield substantial long-term reductions in chronic kidney disease incidence, mortality, and associated healthcare expenditures.
Answers are grounded in this paper and cite their sources.
May support sodium targets to curb CKD burden; extends modeling but leaves open real-world confirmation.
Excess sodium intake raises blood pressure which increases the risk of chronic kidney disease (CKD). We aimed to estimate the impact of reduced sodium intake on future CKD burden in Australia. A multi-cohort proportional multistate lifetable model was developed to estimate the potential impact on CKD burden and health expenditure if the Australian Suggested Dietary Target (SDT) and the National Preventive Health Strategy 2021-2030 (NPHS) sodium target were achieved. Outcomes were projected to 2030 and over the lifetime of adults alive in 2019. Achieving the SDT and NPHS targets could lower population mean systolic blood pressure by 2.1 mmHg and 1.7 mmHg, respectively. Compared to normal routines, attaining the SDT and NPHS target by 2030 could prevent 59,220 (95% UI, 53,140-65,500) and 49,890 (44,377-55,569) incident CKD events, respectively, while postponing 568 (479-652) and 511 (426-590) CKD deaths, respectively. Over the lifetime, this generated 199,488 health-adjusted life years (HALYs) and AUD 644 million in CKD healthcare savings for the SDT and 170,425 HALYs and AUD 514 million for the NPHS. CKD due to hypertension and CKD due to other/unspecified causes were the principal contributors to the HALY gains. Lowering sodium consumption in Australia could deliver substantial CKD health and economic benefits.
No takes yet. Share an insight, caveat, or question.
Aminde et al. (2023) studied Chronic Kidney Disease (CKD). Achieving dietary sodium reduction targets (SDT or NPHS) vs. Business as usual (current average sodium intake of ~3700 mg/day) was evaluated on Incident CKD events prevented by 2030 (SDT target) (59,220 prevented events, 95% CI 53,140-65,500). Achieving the Australian Suggested Dietary Target for sodium by 2030 could prevent 59,220 incident chronic kidney disease events and postpone 568 CKD deaths.
Synapse has enriched 10 related papers. Consider them for comparative context: